Miss Lily Marsden, M.D. Pathology - Forensic Pathology Medicare: Medicare Enrolled Practice Location: 4451 S 2700 W, Taylorsville, UT 84129 Phone: 801-581-2121 |
Neil G. D. Haycocks, M.D., PH.D. Pathology - Hematology Medicare: Not Enrolled in Medicare Practice Location: 4451 S 2700 W, Taylorsville, UT 84129 Phone: 801-816-3850 |
Jacob M. Donnelly, DO Pathology - Forensic Pathology Medicare: Not Enrolled in Medicare Practice Location: 4451 S 2700 W, Taylorsville, UT 84129 Phone: 801-581-2121 |
Dr. Justin M. Lohmann, DO Pathology - Forensic Pathology Medicare: Not Enrolled in Medicare Practice Location: 4451 S 2700 W, Taylorsville, UT 84129 Phone: 801-816-3850 |
Erik Dean Christensen, M.D. Pathology - Forensic Pathology Medicare: Not Enrolled in Medicare Practice Location: 4451 S 2700 W, Taylorsville, UT 84129 Phone: 801-816-3850 Fax: 801-964-1240 |
News Archive
MEDSEEK, the leading provider of healthcare enterprise portal connectivity solutions, announced today that Adena Health System is expanding the capabilities of its existing MEDSEEK-powered eHealth ecoSystem to include additional services that will allow it to remain competitive in a rapidly changing healthcare market. The additional eHealth functionality will meet the increasing demands of today's consumers, further enhance patient satisfaction and solve complex patient referral problems for its community physicians, ultimately improving the delivery and reducing the cost of care.
"In my new working paper, 'Enter the Dragon and the Elephant: China's and India's Participation in Global Health Governance,' I examine these two leading emerging countries' role in global health governance and how further participation can be complicated by domestic health challenges," Yanzhong Huang, a senior fellow for global health at the Council on Foreign Relations, writes in Seton Hall University's "Global Health Governance" blog.
A team of researchers from Osaka University, in cooperation with the Institute for Clinical Research and medical institutes participating in the Kansai Molecular Diagnosis Network for CNS Tumors, conducted the largest-ever retrospective cohort study for Japanese patients with glioblastoma, proposing an underlying prognosis biomarker responsible for the survival difference between two cohorts: an original Japanese cohort and a dataset from The Cancer Genome Atlas.
Three grants totaling more than $4.5 million, from agencies of the National Institutes of Health, will be used to explore novel treatment strategies for muscular dystrophy.
A decision could be issued any day. Also still in the mix is the court's ruling on a First Amendment challenge to a Massachusetts law that established a 35-foot buffer zone to restrict demonstrators outside of abortion clinics.
› Verified 6 days ago